comparemela.com

Latest Breaking News On - Pharma united states inc - Page 2 : comparemela.com

Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic -September 26, 2023 at 11:02 am EDT

NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Sept. 26, 2023 via NewMediaWire - Todos Medical, Ltd. , an innovative healthcare solutions company, today provided a corporate update to.

Canada
New-york
United-states
Mexico
Ghana
Israel
Alpharetta
Georgia
Rehovot
Hamerkaz
Americans
David-cutler

Alembic, Aurobindo Recall Drugs In US Market

Alembic, Aurobindo Recall Drugs In US Market
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

United-states
American
Aurobindo-pharma
Alembic-pharmaceuticals
Aurobindo-pharma-united-states-inc
Alembic-pharmaceuticals-inc
Drug-administration
Enforcement-report
Tobramycin-ophthalmic-solution
Ophthalmic-solution
Jersey-based-alembic-pharmaceuticals-inc
Degradation-specifications

Alembic, Aurobindo recall drugs in US market

Alembic Pharmaceuticals and Aurobindo Pharma are recalling products in the US due to manufacturing problems. Alembic is recalling 82,400 bottles of Tobramycin Ophthalmic Solution due to “Failed Impurities/Degradation Specifications.” Meanwhile, Aurobindo Pharma is recalling 48 bottles of Rufinamide Tablets, in both 200 mg and 400 mg doses, due to cGMP (current good manufacturing practice) deviations, USFDA said. The batch was released prior to approval. Rufinamide tablets are used to treat seizure disorders.

New-delhi
Delhi
India
United-states
American
Aurobindo-pharma
Drug-administration
Alembic-pharmaceuticals
Aurobindo-pharma-united-states-inc
Alembic-pharmaceuticals-inc
Enforcement-report
Tobramycin-ophthalmic-solution

OBI Pharma Announces Executive Leadership Management Change – Heidi Wang, Ph.D. Appointed as Chief Executive Officer

Dr. Wang appointed by the OBI Pharma Board of Directors as Chief Executive Officer to lead OBI Pharma with a vision and to bring innovative cancer therapies to patients globally. She brings a wealth. | June 2, 2023

China
Taiwan
Taipei
T-ai-pei
Taiwanese
Heidi-wang
Kevin-poulos
Adagloxad-simolenin
Bristol-myers-squibb
Futures-bureau
Bristol-myers-squibb-company
Pharma-united-states-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.